Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Weed

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
African Green Monkeys Respond to Synthetic Aβ Oligomers with Persistent Alzheimer's-like ActivationBianca R P Brown, Xiaoting Li, Monica R Grasty, et al.
European Journal of Pharmacology|January 31, 2017
B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptorDebra J Post-Munson, Rick L Pieschl, Thaddeus F Molski, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
A study of the structure-activity relationship of GABA(A)-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysisDongmei Han, F Holger Försterling, Xiaoyan Li, et al.
Neuropathology and Applied Neurobiology|February 14, 2022
Intrathecal amyloid-beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's diseaseDustin R Wakeman, Michael R Weed, Sylvia E Perez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2015
Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species SelectivityMartin A Lewis, Lisa Hunihan, John Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2017
Preclinical Characterization of (<i>R</i>)-3-((3<i>S</i>,4<i>S</i>)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate <i>N</i>-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J Bristow, Jyoti Gulia, Michael R Weed, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
African Green Monkeys Respond to Synthetic Aβ Oligomers with Persistent Alzheimer's-like ActivationBianca R P Brown, Xiaoting Li, Monica R Grasty, et al.
European Journal of Pharmacology|January 31, 2017
B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptorDebra J Post-Munson, Rick L Pieschl, Thaddeus F Molski, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
A study of the structure-activity relationship of GABA(A)-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysisDongmei Han, F Holger Försterling, Xiaoyan Li, et al.
Neuropathology and Applied Neurobiology|February 14, 2022
Intrathecal amyloid-beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's diseaseDustin R Wakeman, Michael R Weed, Sylvia E Perez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2015
Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species SelectivityMartin A Lewis, Lisa Hunihan, John Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2017
Preclinical Characterization of (<i>R</i>)-3-((3<i>S</i>,4<i>S</i>)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate <i>N</i>-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J Bristow, Jyoti Gulia, Michael R Weed, et al.
Pageof 3